Day: August 4, 2021

MANITOWOC, Wis., Aug. 04, 2021 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, controls and IoT systems, including turnkey project implementation, program management and system maintenance, today reported results for its fiscal 2022 first quarter (Q1’22). Orion will hold an investor call today at 10:00 a.m. ET – details below.Q1 Financial Highlights   Prior Three Quarters$ in millions except per share figures Q1’22 Q1’21 Change   Q4’21* Q3’21 Q2’21Revenue $35.1   $10.8   $24.3   $35.5   $44.3   $26.3  Gross Profit $10.2   $2.6   $7.6   $9.2   $11.0   $7.3  Gross Profit % 29.1%   24.4%   +477bps   26.0%   24.9%   27.6%  Net Income (Loss)* $2.5   ($2.2)   $4.7   $22.1   $4.3   $1.9  EPS* $0.08   ($0.07)   $0.15   $0.71   $0.14   $0.06  Net...

TORONTO, Aug. 04, 2021 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital,” “Flow,” or the “Company”) announces that it has closed a follow-on investment of US$1,500,000 in the Pyure Co. (“Pyure”). PYURE designs and manufactures commercial air purifiers that provide dynamic protection against a range of pathogens and improve indoor air quality by eliminating volatile organic compounds and odors. PYURE technology mimics the way sunlight sanitizes the outside environment by safely generating hydroxyls and diffusing organic oxidants indoors. The company’s flagship product is FDA registered as a class II medical device and has been successfully tested for efficacy in reducing airborne SARS-CoV-2, the virus that causes CoVID-19. “Pyure has demonstrated an effective air and surface sanitation solution, which is key to resuming...

New Cartridge Roll-Out Drives News Cycle with Less-Lethal Innovation and Potential Market Disruption An Emerging Markets Sponsored Commentary ORLANDO, Fla., Aug. 04, 2021 (GLOBE NEWSWIRE) — We’re establishing a pattern with featured company KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) which as we’ve mentioned, KWESST develops and commercializes breakthrough next-generation tactical systems that meet the requirements of security forces and personal defense for overmatch capability against adversaries. Simply put, the Company makes news faster than we can cover it. As such, please allow us a moment to give you a pithy update on the Company’s most recent achievements wrapped around their innovative new less-lethal cartridge. It’s all worth noting. KWESST Releases Commercialization Roadmap for Low Energy Cartridge Product Line The...

TORONTO, Aug. 04, 2021 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (TSXV: DGHI; OTCQB: HSSHF) is pleased to announce its financial results for the second quarter ended June 30, 2021 (all amounts in U.S. dollars, unless otherwise indicated). Revenue from digital currency mining was $5.1 million in the second quarter of 2021, a 369% increase over the corresponding quarter in 2020, and a 7% increase over the previous quarter. The Company generated cash flow of $20.3 million in the second quarter of 2021, up significantly from $95k for the same period in 2020, and $7.1 million higher than the previous quarter. Gross profit increased to $2.9 million compared to a gross loss of $1.0 million in Q2 of 2020 and is $0.8 million higher compared to Q1 of 2021. Michel Amar, CEO of Digihost, stated: “We are proud...

Recently obtained FDA approval of TWYNEO® triggers milestone payment from Galderma Exclusive license agreements with Galderma for U.S. commercialization of EPSOLAY® and TWYNEOSol-Gel advancing its early-stage pipeline in plaque psoriasis, palmoplantar keratoderma and other high-value dermatologic indicationsFDA action on the NDA for EPSOLAY still pending due to COVID-19-related restrictionsGeneric ivermectin cream, 1% launched by Sol-Gel’s partner Perrigo in JuneNESS ZIONA, Israel, Aug. 04, 2021 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced financial results for the second quarter ended June 30, 2021 and provided an overview of recent...

SPOKANE, Wash., Aug. 04, 2021 (GLOBE NEWSWIRE) — Avista Corp. (NYSE: AVA) today reported net income of $14.1 million, or $0.20 per diluted share, for the second quarter of 2021, compared to $17.5 million, or $0.26 per diluted share, for the second quarter of 2020. For the six months ended June 30, 2021, net income was $82.1 million, or $1.18 per diluted share, compared to $65.9 million, or $0.98 per diluted share for the six months ended June 30, 2020. “Avista Utilities’ earnings were below expectations for the second quarter due to an increase in net power supply costs, mainly from higher customer loads due to an extended heat wave. We had lower than normal hydroelectric generation due to hot and dry conditions, so we had to rely on additional thermal generation and market purchases at higher costs to serve those additional loads,”...

NEW YORK, Aug. 04, 2021 (GLOBE NEWSWIRE) — Hudson Capital Inc. (NASDAQ: HUSN) (Hudson Capital) announced that FreightHub, Inc. (Fr8Hub), a North American transportation logistics technology platform company focused on US-Mexico cross-border shipping with which Hudson Capital has signed a definitive Merger Agreement, appointed Luisa Irene Lopez as its new Chief Operating Officer, effective August 2, 2021. Lopez will report to Javier Selgas, Fr8Hub’s Chief Executive Officer, and will be responsible for overall business strategy, operations, customer service, and strategic vendor oversight. “Luisa is a seasoned and trusted leader in the freight industry who has a proven track record leading operational excellence and has established a network of operators throughout North America,” stated Selgas. “With her extensive international...

ALPHARETTA, Ga., Aug. 04, 2021 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will participate in two upcoming investor conferences in August 2021: Wedbush PacGrow Healthcare Virtual ConferencePanel Discussion: GoldeneyeWednesday, August 11, 2021 at 9:45 am ET H.C. Wainwright Ophthalmology Virtual ConferencePanel Discussion: Vision Repair Beyond Traditional Anti-VEGF TherapyTuesday, August 17, 2021 at 12:00 pm ETCorporate Presentation available Tuesday, August 17, 2021 at 7:00 am...

Radisson Resort Kolobrzeg Persante RestaurantRadisson Resort Kolobrzeg Persante RestaurantRadisson Resort Kolobrzeg Poland aqua park slideRadisson Resort Kolobrzeg Poland aqua park slideRadisson Resort Kolobrzeg Poland exteriorRadisson Resort Kolobrzeg Poland exteriorRadisson Resort Kolobrzeg Poland family room nature viewRadisson Resort Kolobrzeg Poland family room nature viewRadisson Resort Kolobrzeg rooftop poolRadisson Resort Kolobrzeg rooftop poolRadisson Resort Kolobrzeg spaRadisson Resort Kolobrzeg spaRadisson Resort Kolobrzeg Persante RestaurantRadisson Resort Kolobrzeg Persante RestaurantRadisson Resort Kolobrzeg Poland aqua park slideRadisson Resort Kolobrzeg Poland aqua park slideRadisson...

MAINZ, Germany & Santa Monica, USA, August 4, 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the closing of the acquisition of the solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility’s assets and leases in Gaithersburg, MD, from Kite. The transaction was announced on July 19, 2021. The acquisition strengthens BioNTech’s cell therapy pipeline by accelerating the individualized solid tumor Neoantigen TCR cell therapy research and development program. It also expands the Company’s cell therapy capabilities and manufacturing footprint in North America, building on its acquisition of Neon Therapeutics in 2020. With three acquisitions completed in the last 14 months, BioNTech confirms its strategy of complementing organic growth...